Form 4: Oracle CEO Safra Catz Exercises Stock Options and Sells Over 1.2 Million Shares Under Pre-Arranged Plan
Insider Transaction Report
Oracle CEO Safra Catz reported the exercise of stock options and subsequent sale of 1,260,508 shares of Oracle common stock on June 27, 2025, executed under a Rule 10b5-1 trading plan.
Summary
- Safra Catz, Oracle's Chief Executive Officer and a Director, reported transactions involving Oracle common stock on June 27, 2025.
- Exercised stock options to acquire 1,260,508 shares of Oracle Common Stock at an exercise price of $51.13 per share.
- Simultaneously disposed of 1,260,508 shares of Oracle Common Stock through multiple sales.
- The sales were executed at weighted average prices ranging from $210.3509 to $214.2475 per share.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan that was adopted on September 25, 2024.
- The exercised option represented 2/7 of a performance-based option that vested upon certification of a performance goal by the Compensation Committee.
- Following these transactions, Safra Catz's direct beneficial ownership of Oracle Common Stock is 1,118,592 shares.
Sentiment
Score: 6
Explanation: The transactions represent a pre-planned exercise of performance-based stock options and subsequent sale of shares by a key executive, indicating the achievement of performance goals and planned liquidity. While significant insider selling can sometimes be viewed negatively, the execution under a 10b5-1 plan mitigates concerns about reactive selling, leading to a neutral to slightly positive sentiment.
Positives
- The exercise of performance-based stock options indicates the achievement of specific performance goals set by the Compensation Committee.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests planned liquidity and diversification rather than a reaction to immediate market conditions or negative company news.
Negatives
- The significant sale of shares by a key executive, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.
Future Outlook
NA
Management Comments
- Sales were executed pursuant to a Rule 10b5-1 Plan adopted on September 25, 2024.
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the executive's sale as a signal, though the pre-planned nature via a 10b5-1 plan typically reduces concerns about negative implications.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 09/25/2024 | Rule 10b5-1 Plan adopted by Safra Catz. |
| 06/24/2025 | Date the performance-based stock option became exercisable. |
| 06/27/2025 | Transaction date for both the exercise of stock options and the subsequent sale of common stock. |
| 07/01/2025 | Date the Form 4 filing was signed and submitted. |
| 07/20/2025 | Expiration date of the exercised stock option. |
Recommendation
holdKeywords
Oracle, ORCL, Safra Catz, SEC Form 4, Insider Trading, Stock Options, 10b5-1 Plan, CEO, Director, Share Sale, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.